https://www.selleckchem.com/pr....oducts/darapladib-sb
8%). The reporting of radiotherapy characteristics did not improve during the 2010 s-2019s. Acute and late high-grade toxicity was reported in 37.7 and 30.7%, respectively. Their reporting decreased in recent period, especially for all-grade late toxicities ( = 0.044). It seems necessary to meet stricter specifications to improve the quality of reporting. Our work results in one of the rare analyses of radiosurgery and SBRT publications. Literature must include necessary information to first, ensure treatments can be compar
Like
Comment
Share
